1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
1/2 NCCU-DUKE 癌症差异转化研究合作伙伴关系
基本信息
- 批准号:9246378
- 负责人:
- 金额:$ 23.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-20 至 2020-08-31
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAddressAdvanced Malignant NeoplasmAdvisory CommitteesAfrican AmericanAttentionBioinformaticsBiological SciencesBiomanufacturingBiomedical ResearchCancer CenterCancer ControlCancer PatientClinicClinicalClinical TrialsCollaborationsCollectionCommunitiesCommunity Health EducationCommunity OutreachComplementComprehensive Cancer CenterContractsDetectionDevelopmentDiseaseDoctor of PhilosophyEducationEducation and OutreachEducational workshopEvaluationFacultyFosteringGenomicsHistorically Black Colleges and UniversitiesHumanHuman Subject ResearchInstitutesInstitutionIntellectual PropertyJointsLeadershipMalignant NeoplasmsMalignant neoplasm of prostateMedical centerMentorsMinorityMinority Graduate StudentModelingMolecularNCI-Designated Cancer CenterNorth CarolinaOutcomePathway interactionsPharmacologic SubstancePhasePilot ProjectsPopulationPostdoctoral FellowPreventionProceduresProcessProgram EvaluationProstateRecording of previous eventsRecruitment ActivityResearchResearch InfrastructureResearch InstituteResearch PersonnelResearch Project GrantsResearch TrainingResource SharingResourcesSTEM fieldScienceStagingStrategic PlanningSystemTechnologyTrainingTraining ProgramsTraining and EducationTranslational ResearchTranslational Research Working GroupUnderrepresented MinorityUnderrepresented StudentsUnderserved PopulationUnited States National Institutes of HealthUniversitiesWomanWorkanticancer researchbasecancer carecancer health disparitycancer preventioncancer therapycareer developmentcomputational chemistrydata sharingdirect applicationdrug developmentdrug discoveryeducation researchgraduate studenthealth disparityhealth equityinflammatory breast cancerinfrastructure developmentinnovationlongitudinal databasemeetingsmembermennext generationorganizational structureprogramsracial diversitystudent trainingsymposiumtumorundergraduate studentunderrepresented minority studentunderserved minority
项目摘要
ABSTRACT
The North Carolina Central University (NCCU) – DUKE Cancer Disparities Translational Research Partnership
(NCCU-DCI-CDTRP) is focused on developing infrastructure for translational cancer health disparities
research, education and training and on performing two such pilot research projects, focusing on the molecular
aspects underlying the increased lethality of prostate and inflammatory breast cancer in African Americans,
with direct application to prevention, detection and treatment. This Program is built on the long-standing
relationship between the two Durham-based Institutions, less than four miles apart. NCCU is an Institution
Serving Underserved health disparity Populations and underrepresented Students (ISUPS), affiliated with the
17-member University of North Carolina system and the Duke Cancer Institute (DCI) is an NCI-designated
Comprehensive Cancer Center (CC). The Partnership, focusing on translational cancer health disparities
research and education and training of graduate students, postdoctoral fellows and early stage investigators
(ESIs) in this field, which is described by the NIH Translational Research Working Group, will distinguish itself
with synergistic complementarity to an existing U54 between NCCU and UNC, which focuses on sociocultural
disparities research and education and training of undergraduate students. To this Partnership, the
Biomanufacturing Research Institute and Technology Enterprise (BRITE) faculty at NCCU will bring a unique
perspective from an ISUPS, expertise in pharmaceuticals, drug discovery and development, as well as existing
extensive health disparities education and training programs. The CC, DCI, will bring a unique distinguishing
focus on biospecimen collection, correlative science in the context of clinical trials, development of racially
diverse cancer patient-derived models and programs addressing minority accrual to treatment and
biospecimen collection clinical trials. Development of the Partnership occurred and is continuing around
planning and priority-setting stages, including selection of co-developed, collaborative pilot research projects
and creation of a fully integrated, bi-directional, mutually beneficial Cancer Research Education Program
(CREP). The Implementation stage will launch the pilot research projects, utilizing nearly 25 Shared Resources
between NCCU and Duke, the CREP and the engagement of underserved minority populations across the
region and state, with complementary existing programming mutually emanating from NCCU, which directly
serves a minority community, and DCI’s Office of Health Equity and Disparities. The Partnership will be led by
an integrated Administrative Core of senior investigators who will serve as mentors to ESIs, rigorously
addressing career development, to postdoctoral fellows and to graduate students and will include an extensive
Evaluation Program for tracking impact and outcomes. The Partnership will be guided by an Internal Advisory
Committee (IAC), an External Advisory Committee (EAC), focused solely on scientific guidance, and a
Community Advisory Board (CAB).
抽象的
北卡罗来纳州中央大学(NCCU) - 杜克癌症差异转化研究伙伴关系
(NCCU-DCI-CDTRP)专注于开发用于转化癌症健康分布的基础设施
研究,教育和培训以及执行两个这样的试点研究项目,重点是分子
非洲裔美国人的前列腺和炎症性乳腺癌致死率增加的基础
直接应用预防,检测和治疗。该程序建立在长期以来的
两个基于达勒姆的机构之间的关系,相距不到四英里。 NCCU是一个机构
为服务不足的健康差异人群和代表性不足的学生(ISUP)提供服务
由17名成员的北卡罗来纳大学系统和杜克癌症研究所(DCI)是NCI指定的
综合癌症中心(CC)。伙伴关系,重点是翻译的癌症健康分布
研究,教育和培训研究生,博士后研究员和早期调查员
NIH转化研究工作组描述的(ESI)将会区分自己
与NCCU和UNC之间的现有U54的协同互补性,重点是社会文化
本科生的差异研究和教育和培训。对于这种伙伴关系,
NCCU的生物制造研究所和技术企业(BRITE)教师将带来独特的
ISUP的观点,药品专业知识,药物发现和开发以及现有
广泛的健康分配教育和培训计划。 CC,DCI将带来独特的区别
专注于临床试验的背景下的生物传播收集,相关科学,种族发展
潜水癌症患者衍生的模型和计划,以解决少数群体的治疗准确性和
Biospecimen Collection临床试验。伙伴关系的发展发生并正在继续
计划和优先设定阶段,包括选择共同开发的协作试点研究项目
并创建完全整合,双向,互惠互利的癌症研究教育计划
(Crep)。实施阶段将使用近25个共享资源启动试点研究项目
在NCCU和DUKE之间,CREP和服务不足的少数群体的参与
地区和州,由NCCU直接从NCCU散发的现有编程
为少数族裔社区和DCI的卫生公平与差异办公室服务。合伙企业将由
高级调查员的综合行政核心,将担任ESI的导师
针对职业发展,向博士后研究员和研究生致敬,并将包括广泛的
跟踪影响和结果的评估计划。合作伙伴关系将以内部咨询为指导
外部咨询委员会(EAC)委员会(IAC)仅着眼于科学指导,
社区顾问委员会(CAB)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN R PATIERNO其他文献
STEVEN R PATIERNO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN R PATIERNO', 18)}}的其他基金
Duke Cancer Health Disparities P20 SPORE
杜克大学癌症健康差异 P20 SPORE
- 批准号:
10263341 - 财政年份:2020
- 资助金额:
$ 23.49万 - 项目类别:
Duke Cancer Health Disparities P20 SPORE
杜克大学癌症健康差异 P20 SPORE
- 批准号:
10037506 - 财政年份:2020
- 资助金额:
$ 23.49万 - 项目类别:
Race-related alternative splicing: novel targets in prostate cancer
种族相关的选择性剪接:前列腺癌的新靶点
- 批准号:
10153715 - 财政年份:2017
- 资助金额:
$ 23.49万 - 项目类别:
Race-related alternative splicing: novel targets in prostate cancer
种族相关的选择性剪接:前列腺癌的新靶点
- 批准号:
9925752 - 财政年份:2017
- 资助金额:
$ 23.49万 - 项目类别:
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
2/2 NCCU-DUKE 癌症差异转化研究合作伙伴关系
- 批准号:
9353735 - 财政年份:2016
- 资助金额:
$ 23.49万 - 项目类别:
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
2/2 NCCU-DUKE 癌症差异转化研究合作伙伴关系
- 批准号:
9762865 - 财政年份:2016
- 资助金额:
$ 23.49万 - 项目类别:
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
2/2 NCCU-DUKE 癌症差异转化研究合作伙伴关系
- 批准号:
9246679 - 财政年份:2016
- 资助金额:
$ 23.49万 - 项目类别:
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
1/2 NCCU-DUKE 癌症差异转化研究合作伙伴关系
- 批准号:
9763335 - 财政年份:2016
- 资助金额:
$ 23.49万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Southwest EDRN Clinical Validation Center for Head and Neck Cancer
西南头颈癌EDRN临床验证中心
- 批准号:
10706931 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
Text-messaging Communication Micro-Intervention for Couples Coping with Advanced GI Cancer
针对晚期胃肠道癌症夫妇的短信沟通微干预
- 批准号:
10607060 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management
GARDE:个性化癌症风险管理的可扩展临床决策支持
- 批准号:
10741231 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
Vanderbilt-Zambia Cancer Research Training Program (VZCARE)
范德比尔特-赞比亚癌症研究培训计划 (VZCARE)
- 批准号:
10596631 - 财政年份:2022
- 资助金额:
$ 23.49万 - 项目类别:
Vanderbilt-Zambia Cancer Research Training Program (VZCARE)
范德比尔特-赞比亚癌症研究培训计划 (VZCARE)
- 批准号:
10435831 - 财政年份:2022
- 资助金额:
$ 23.49万 - 项目类别: